+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Porcine Vaccines Market by Indication, Technology, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715935
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Porcine Vaccines Market grew from USD 1.71 billion in 2023 to USD 1.82 billion in 2024. It is expected to continue growing at a CAGR of 6.72%, reaching USD 2.70 billion by 2030.

Porcine vaccines play a crucial role in swine health management by preventing infectious diseases that can significantly impact pig populations and the pork industry. These vaccines are essential for controlling outbreaks, ensuring animal welfare, and enhancing the efficiency and sustainability of pork production. They are used in various applications, including prevention of diseases such as Porcine Circovirus, Mycoplasma Pneumonia, and Classical Swine Fever, with significant end-use across pig farms, veterinary hospitals, and research institutes. The market growth for porcine vaccines is primarily driven by increasing awareness about animal health, rising demand for safe and effective animal protein, and the economic necessity of minimizing healthcare costs associated with livestock diseases. Innovations in vaccine delivery, such as oral and intranasal routes, and advancements in biotechnology, particularly in genetically engineered vaccines, present significant opportunities for market players. However, challenges include stringent regulatory frameworks, high research and development costs, and the need for cold chain logistics which can limit market expansion, especially in emerging regions. Key recommendations for capturing growth opportunities include investing in research and development to create more effective and easy-to-administer vaccines, partnerships with government and non-governmental organizations for disease eradication programs, and expanding distribution networks in developing markets where demand for pork is rising. Limitations involve varying animal health regulations across different countries and potential resistance from farmers due to cost constraints and lack of awareness. The best areas for innovation and research include overcoming these challenges through cost-effective vaccine production technologies, developing vaccines based on novel biological targets, and exploring bioinformatics for predictive modeling of disease outbreaks. The porcine vaccine market is dynamic, necessitating firms to remain adaptable to market changes while contributing to improved food safety and security.

Understanding Market Dynamics in the Porcine Vaccines Market

The Porcine Vaccines Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rise in Prevalence of Swine Diseases Worldwide
    • Increasing Demand for High-Quality Pork Meat
    • Government Initiatives to Support Animal Health
  • Market Restraints
    • High Cost of Porcine Vaccine Development and Complex Storage Issues
  • Market Opportunities
    • Technological Advancements in Porcine Vaccine
    • Favorable Investment Landscape For Production of Novel Porcine Vaccines
  • Market Challenges
    • Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines

Exploring Porter’s Five Forces for the Porcine Vaccines Market

Porter’s Five Forces framework further strengthens the insights of the Porcine Vaccines Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Porcine Vaccines Market

External macro-environmental factors deeply influence the performance of the Porcine Vaccines Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Porcine Vaccines Market

The Porcine Vaccines Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Porcine Vaccines Market

The Porcine Vaccines Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Endovac Animal Health, Merck & Co., Inc., FATRO S.p.A., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Yenher Agro-Products Sdn. Bhd., Boehringer Ingelheim International GmbH, Biogénesis Bagó S.A., Formosa Biomedical Inc., Indian Immunologicals Ltd., Kyoto Biken Laboratories, Inc., PBS Animal Health, Bimeda Holdings PLC, HIPRA, S.A., Zoetis Inc., Aptimmune Biologics, Inc., AVAC Vietnam Joint Stock Company, Eli Lilly and Company, Phibro Animal Health Corporation, Arko Laboratories, Genvax Technologies, Inc., Nisseiken Co., Ltd., Medgene Labs, Virbac SA, Ceva Sante Animale, and KM Biologics Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Porcine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Indication
    • Arthritis
    • Diarrhea
    • Porcine Circovirus Associated Disease
    • Porcine Reproductive & Respiratory Syndrome
    • Swine Influenza
  • Technology
    • Conjugate Vaccines
    • DNA Vaccines
    • Inactivated Vaccines
    • Live attenuated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
  • End User
    • Hog/Pig Production Farm
    • Veterinary Clinics/Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in Prevalence of Swine Diseases Worldwide
5.1.1.2. Increasing Demand for High-Quality Pork Meat
5.1.1.3. Government Initiatives to Support Animal Health
5.1.2. Restraints
5.1.2.1. High Cost of Porcine Vaccine Development and Complex Storage Issues
5.1.3. Opportunities
5.1.3.1. Technological Advancements in Porcine Vaccine
5.1.3.2. Favorable Investment Landscape For Production of Novel Porcine Vaccines
5.1.4. Challenges
5.1.4.1. Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines
5.2. Market Segmentation Analysis
5.2.1. Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
5.2.2. End User: Growing need for mass vaccination programs in the hog/pig production farm
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
5.5. Client Customization
6. Porcine Vaccines Market, by Indication
6.1. Introduction
6.2. Arthritis
6.3. Diarrhea
6.4. Porcine Circovirus Associated Disease
6.5. Porcine Reproductive & Respiratory Syndrome
6.6. Swine Influenza
7. Porcine Vaccines Market, by Technology
7.1. Introduction
7.2. Conjugate Vaccines
7.3. DNA Vaccines
7.4. Inactivated Vaccines
7.5. Live attenuated Vaccines
7.6. Recombinant Vaccines
7.7. Toxoid Vaccines
8. Porcine Vaccines Market, by End User
8.1. Introduction
8.2. Hog/Pig Production Farm
8.3. Veterinary Clinics/Hospitals
9. Americas Porcine Vaccines Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Porcine Vaccines Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Porcine Vaccines Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Zoetis Launches Circomax In The UK
12.3.2. Merck Animal Health Launches 3-In-One Swine Vaccine
12.3.3. Elanco is Exclusive U.S. Distributor of Aptimmune’s PRRS Killed Autogenous Vaccine
List of Figures
FIGURE 1. PORCINE VACCINES MARKET RESEARCH PROCESS
FIGURE 2. PORCINE VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PORCINE VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PORCINE VACCINES MARKET DYNAMICS
TABLE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 151. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Porcine Vaccines market, which are profiled in this report, include:
  • Bayer AG
  • Endovac Animal Health
  • Merck & Co., Inc.
  • FATRO S.p.A.
  • Malaysian Vaccines & Pharmaceuticals Sdn Bhd.
  • Yenher Agro-Products Sdn. Bhd.
  • Boehringer Ingelheim International GmbH
  • Biogénesis Bagó S.A.
  • Formosa Biomedical Inc.
  • Indian Immunologicals Ltd.
  • Kyoto Biken Laboratories, Inc.
  • PBS Animal Health
  • Bimeda Holdings PLC
  • HIPRA, S.A.
  • Zoetis Inc.
  • Aptimmune Biologics, Inc.
  • AVAC Vietnam Joint Stock Company
  • Eli Lilly and Company
  • Phibro Animal Health Corporation
  • Arko Laboratories
  • Genvax Technologies, Inc.
  • Nisseiken Co., Ltd.
  • Medgene Labs
  • Virbac SA
  • Ceva Sante Animale
  • KM Biologics Co., Ltd.

Methodology

Loading
LOADING...

Table Information